Anti-β2-glycoprotein I/HLA-DR Antibody and Adverse Obstetric Outcomes

Anti-β2-glycoprotein I/HLA-DR (anti-β2GPI/HLA-DR) antibody has been reported to be associated with antiphospholipid syndrome and recurrent pregnancy loss (RPL). We conducted a prospective multicenter cross-sectional study aimed at evaluating whether the anti-β2GPI/HLA-DR antibody is associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanimura, Kenji, Saito, Shigeru, Tsuda, Sayaka, Ono, Yosuke, Ota, Hajime, Wada, Shinichiro, Deguchi, Masashi, Nakatsuka, Mikiya, Nagamatsu, Takeshi, Fujii, Tomoyuki, Kobashi, Gen, Arase, Hisashi, Yamada, Hideto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342169/
https://www.ncbi.nlm.nih.gov/pubmed/37446134
http://dx.doi.org/10.3390/ijms241310958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342169/
https://www.ncbi.nlm.nih.gov/pubmed/37446134
http://dx.doi.org/10.3390/ijms241310958

Ejemplares similares